☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Eli Lilly's Olumiant (baricitinib) Receives FDA Approval for Moderately-to-Severely Active Rheumatoid Arthritis (RA) in Adults
October 8, 2018
PharmaShots Weekly Snapshot (01 Oct-06 Oct,2018)
October 8, 2018
Novartis Announces Acceptance of its Novel Siponimod (BAF312) by the US FDA and EMA
October 8, 2018
Merck's Gardasil 9 Receives FDA's Expanded Label Approval for Prevention of HPV Related Disorders
October 8, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions